Jindřich Fínek, Michal Vočka, Jan Bauer, Eugen Kubala, Kateřina Zycháčková, Marcela Šedivá, Mahmud Gharibyar, Ilona Kocáková, Eva Čmuchařová, Marie Vaňková
{"title":"在接受西妥昔单抗治疗的 RAS 野生型转移性结直肠癌患者中,将早期肿瘤缩小作为潜在预测指标应用于日常临床实践的可行性--一项非干预性观察研究","authors":"Jindřich Fínek, Michal Vočka, Jan Bauer, Eugen Kubala, Kateřina Zycháčková, Marcela Šedivá, Mahmud Gharibyar, Ilona Kocáková, Eva Čmuchařová, Marie Vaňková","doi":"10.48095/ccko2024110","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":35565,"journal":{"name":"Klinicka Onkologie","volume":"46 9","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-04-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Feasibility of implementation of the early tumor shrinkage as a potential predictive marker to daily clinical practice in patients with RAS wild type metastatic colorectal cancer, treated with cetuximab – a non-interventional observational study\",\"authors\":\"Jindřich Fínek, Michal Vočka, Jan Bauer, Eugen Kubala, Kateřina Zycháčková, Marcela Šedivá, Mahmud Gharibyar, Ilona Kocáková, Eva Čmuchařová, Marie Vaňková\",\"doi\":\"10.48095/ccko2024110\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":35565,\"journal\":{\"name\":\"Klinicka Onkologie\",\"volume\":\"46 9\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-04-15\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Klinicka Onkologie\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.48095/ccko2024110\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"Medicine\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Klinicka Onkologie","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.48095/ccko2024110","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Medicine","Score":null,"Total":0}
Feasibility of implementation of the early tumor shrinkage as a potential predictive marker to daily clinical practice in patients with RAS wild type metastatic colorectal cancer, treated with cetuximab – a non-interventional observational study